Sham Nambulli

2.2k total citations · 2 hit papers
21 papers, 1.0k citations indexed

About

Sham Nambulli is a scholar working on Infectious Diseases, Epidemiology and Genetics. According to data from OpenAlex, Sham Nambulli has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 6 papers in Genetics. Recurrent topics in Sham Nambulli's work include Virology and Viral Diseases (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Virus-based gene therapy research (5 papers). Sham Nambulli is often cited by papers focused on Virology and Viral Diseases (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Virus-based gene therapy research (5 papers). Sham Nambulli collaborates with scholars based in United States, Netherlands and United Kingdom. Sham Nambulli's co-authors include W. Paul Duprex, Linda J. Rennick, William Bain, Kevin R. McCarthy, Lindsey R. Robinson‐McCarthy, Ghady Haidar, Yufei Xiang, Zhe Sang, Yi Shi and Dina Schneidman‐Duhovny and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Sham Nambulli

20 papers receiving 994 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

2021 332 citations Kevin R. McCarthy, Linda J. Rennick et al. Science profile →
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2

2020 265 citations Yufei Xiang, Sham Nambulli et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sham Nambulli United States	11	761	272	244	202	135	21	1.0k
Rachel S. Nargi United States	10	840 1.1×	316 1.2×	171 0.7×	131 0.6×	54 0.4×	15	997
Rachel Eguia United States	12	1.3k 1.7×	446 1.6×	166 0.7×	192 1.0×	69 0.5×	13	1.6k
Laura A. VanBlargan United States	13	1.4k 1.8×	421 1.5×	166 0.7×	149 0.7×	65 0.5×	21	1.6k
John M. Errico United States	11	979 1.3×	288 1.1×	131 0.5×	83 0.4×	58 0.4×	14	1.2k
Sandhya Bangaru United States	14	658 0.9×	322 1.2×	229 0.9×	402 2.0×	59 0.4×	26	1.1k
Brian D. Quinlan United States	12	819 1.1×	430 1.6×	97 0.4×	107 0.5×	78 0.6×	17	1.3k
Dorien De Vlieger Belgium	8	361 0.5×	219 0.8×	233 1.0×	98 0.5×	94 0.7×	9	602
Christopher A. Cottrell United States	14	461 0.6×	367 1.3×	212 0.9×	185 0.9×	81 0.6×	24	941
Louis-Marie Bloyet United States	15	744 1.0×	318 1.2×	59 0.2×	275 1.4×	77 0.6×	23	1.1k
Laura Perez Vidakovics Sweden	15	337 0.4×	293 1.1×	202 0.8×	266 1.3×	103 0.8×	22	906

Countries citing papers authored by Sham Nambulli

Since Specialization

Citations

This map shows the geographic impact of Sham Nambulli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sham Nambulli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sham Nambulli more than expected).

Fields of papers citing papers by Sham Nambulli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sham Nambulli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sham Nambulli. The network helps show where Sham Nambulli may publish in the future.

Co-authorship network of co-authors of Sham Nambulli

This figure shows the co-authorship network connecting the top 25 collaborators of Sham Nambulli. A scholar is included among the top collaborators of Sham Nambulli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sham Nambulli. Sham Nambulli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nambulli, Sham, Nicolas Escriou, Linda J. Rennick, et al.. (2024). A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. Journal of Virology. 98(5). e0176223–e0176223. 1 indexed citations

Schmitz, Katharina S., Geert van Amerongen, Laurine C. Rijsbergen, et al.. (2023). Inoculation of raccoons with a wild-type-based recombinant canine distemper virus results in viremia, lymphopenia, fever, and widespread histological lesions. mSphere. 8(4). e0014423–e0014423. 3 indexed citations

Laksono, Brigitta M., Anouskha D. Comvalius, Katharina S. Schmitz, et al.. (2023). Infection of ferrets with wild type-based recombinant canine distemper virus overwhelms the immune system and causes fatal systemic disease. mSphere. 8(4). 4 indexed citations

Gilliland, Theron, Rong Li, Sham Nambulli, et al.. (2023). Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variants. iScience. 26(10). 107764–107764. 3 indexed citations

Guseman, Alex J., Linda J. Rennick, Sham Nambulli, et al.. (2023). Targeting spike glycans to inhibit SARS-CoV2 viral entry. Proceedings of the National Academy of Sciences. 120(38). e2301518120–e2301518120. 5 indexed citations

Ambrose, Zandrea, Ralph S. Baric, Fatema Bhinderwala, et al.. (2023). Targeting spike glycans to inhibit SARS-CoV2 viral entry. UNC Libraries. 1 indexed citations

Xiang, Yufei, Wei Huang, Hejun Liu, et al.. (2022). Superimmunity by pan-sarbecovirus nanobodies. Cell Reports. 39(13). 111004–111004. 22 indexed citations

Nambulli, Sham, Linda J. Rennick, Natasha L. Tilston‐Lunel, et al.. (2022). FeMV is a cathepsin-dependent unique morbillivirus infecting the kidneys of domestic cats. Proceedings of the National Academy of Sciences. 119(43). e2209405119–e2209405119. 8 indexed citations

Tilston‐Lunel, Natasha L., Stephen R. Welch, Sham Nambulli, et al.. (2021). Sustained Replication of Synthetic Canine Distemper Virus Defective Genomes In Vitro and In Vivo. mSphere. 6(5). e0053721–e0053721. 11 indexed citations

10.

McCarthy, Kevin R., Linda J. Rennick, Sham Nambulli, et al.. (2021). Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science. 371(6534). 1139–1142. 332 indexed citations breakdown →

11.

Nambulli, Sham, Yufei Xiang, Natasha L. Tilston‐Lunel, et al.. (2021). Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses. Science Advances. 7(22). 107 indexed citations

12.

Laksono, Brigitta M., Diana Tran, Ivanela Kondova, et al.. (2021). Comparable Infection Level and Tropism of Measles Virus and Canine Distemper Virus in Organotypic Brain Slice Cultures Obtained from Natural Host Species. Viruses. 13(8). 1582–1582. 5 indexed citations

13.

Klimstra, William B., Natasha L. Tilston‐Lunel, Sham Nambulli, et al.. (2020). SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients. Journal of General Virology. 101(11). 1156–1169. 86 indexed citations

14.

Xiang, Yufei, Sham Nambulli, Zhengyun Xiao, et al.. (2020). Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2. Science. 370(6523). 1479–1484. 265 indexed citations breakdown →

15.

Barbeau, Dominique J., Joseph R. Albe, Sham Nambulli, et al.. (2020). Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret. mSphere. 5(5). 16 indexed citations

16.

Rennick, Linda J., et al.. (2020). Recombinant subtype A and B human respiratory syncytial virus clinical isolates co-infect the respiratory tract of cotton rats. Journal of General Virology. 101(10). 1056–1068. 8 indexed citations

17.

Rissanen, Ilona, Asim Ahmed, Kristopher D. Azarm, et al.. (2017). Idiosyncratic Mòjiāng virus attachment glycoprotein directs a host-cell entry pathway distinct from genetically related henipaviruses. Nature Communications. 8(1). 16060–16060. 47 indexed citations

18.

Nambulli, Sham, et al.. (2016). Mapping the evolutionary trajectories of morbilliviruses: what, where and whither. Current Opinion in Virology. 16. 95–105. 38 indexed citations

19.

Wilson, Michael R., Greg Fedewa, Mark D. Stenglein, et al.. (2016). Multiplexed Metagenomic Deep Sequencing To Analyze the Composition of High-Priority Pathogen Reagents. mSystems. 1(4). 10 indexed citations

20.

Ludlow, Martin, Linda J. Rennick, Sham Nambulli, Rik L. de Swart, & W. Paul Duprex. (2013). Using the ferret model to study morbillivirus entry, spread, transmission and cross-species infection. Current Opinion in Virology. 4. 15–23. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact